Levels of plasma fibrinogen and D-dimer in subjects with subclinical hyperthyroidism

Medical Science Monitor

Volumn 14, Issue 1, 2008, Pages

  Coban, Erkan ^a   Aydemir, Mustafa ^a  

^a AKDENIZ UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Cardiovascular risk; D dimer; Fibrinogen; Subclinic hyperthyroidism

Indexed keywords

D DIMER; FIBRINOGEN;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; EUTHYROIDISM; FEMALE; FIBRINOGEN BLOOD LEVEL; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HUMAN; HYPERTHYROIDISM; LABORATORY TEST; MALE; THYROTROPIN BLOOD LEVEL;

ADULT; ATHEROSCLEROSIS; CASE-CONTROL STUDIES; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; HUMANS; HYPERTHYROIDISM; MALE; MIDDLE AGED; RISK FACTORS; THROMBOEMBOLISM;

EID: 38149084215     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Kamath S, Lip GY: Fibrinogen: biochemistry, epidemiology and determinants. QJM, 2003; 96: 711-29
2. Meade TW, North WRS, Chakrabarti R et al: Haemostatic function and cardiovascular death: early results of a prospective study. Lancet, 1980; 1: 1050-54
3. Wilhelmsen L, Svardsudd K, Korsan-Bengsten K et al: Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med, 1984; 31: 501-5
4. Stone MC, Thorp JM: Plasma fibrinogen: a major coronary risk factor. J R Coll Gen Pract, 1985; 35: 565-69
5. Meade TW, Mellows S, Brozovic M et al: Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet, 1986; 2: 533-37
6. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB: Fibrinogen and risk of cardiovascular disease: the Framingham Study. JAMA, 1987; 258: 1183-86
7. Yarnell JWG, Baker IA, Sweetnam PM et al: Fibrinogen, viscosity and white blood cell count are major risk factors for ischaemic heart disease: the Caerphilly and Speedwell Collaborative Heart Disease Studies. Circulation, 1991; 83: 836-44
8. Lowe GDO, Fowkes FGR, Dawes J et al: Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh artery study. Circulation, 1993; 87: 1915-20
9. Folsom AR, Aleksic N, Park E et al: Prospective study of fibrinolytic factors and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study. Arterioscler Thromb Vasc Biol, 2001; 21: 611-17
10. Ridker PM, Hennekens CH, Cerskus A, Stampfer MJ: Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men. Circulation, 1994; 90: 2236-40
11. Smith FB, Lee AJ, Fowkes FG et al: Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study. Arterioscler Thromb Vasc Biol, 1997; 17: 3321-25
12. Lowe GD, Yarnell JW, Sweetnam PM et al: Fibrin D-dimer, tissue plasminogen activator, plasminogen activator inhibitor, and the risk of major ischaemic heart disease in the Caerphilly Study. Thromb Haemost, 1998; 79: 129-33
13. Cushman M, Lemaitre RN, Kuller LH et al: Fibrinolytic activation markers predict myocardial infarction in the elderly: the Cardiovascular Health Study Arterioscler Thromb Vasc Biol, 1999; 19: 493-98
14. Moss AJ, Goldstein RE, Marder VJ et al: Thrombogenic factors and recurrent coronary events. Circulation, 1999; 99: 2517-22
15. Biondi B, Palmieri EA, Klain M et al: Subclinical hyperthyroidism: clinical features and treatment options. Eur J Endocrinol, 2005; 152: 1-9
16. Canaris GJ, Manovitz NR, Mayor G, Ridgway EC: The Colorado thyroid disease prevalence study. Arch Intern Med, 2000; 160: 526-34
17. Marqusee E, Haden ST, Utiger RD: Subclinical thyrotoxicosis. Endocrinol Metab Clin North Am, 1998; 27: 37-49
18. Wang C, Crapo LM: The epidemiology of thyroid diseases and implications for screening. Endocrinol Metab Clin North Am, 1977; 26: 189-218
19. Samuels MH: Subclinical thyroid disease in the elderly. Thyroid, 1998; 8: 803-13
20. Col NF, Surks MI, Daniels GH: Subclinical thyroid disease: clinical applications. JAMA, 2004; 291: 239-43
21. Erem C, Ersoz HO, Karti SS et al: Blood coagulation and fibrinolysis in patients with hyperthyroidism. J Endocrinol Invest, 2002; 25: 345-50
22. Burggraaf J, Lalezari S, Emeis JJ et al: Endothelial function in patients with hyperthyroidism before and after treatment with propranolol and thiamazol. Thyroid, 2001; 11: 153-60
23. Marangiu F, Conti M, Murtas ML et al: Activation of blood coagulation and fibrinolysis in Graves' disease. Horm Metab Res, 1991; 23: 609-11
24. Erem C: Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity. Clin Endocrinol (Oxf), 2006; 64: 323-29
25. Friedewald WT, Levi RI, Fredricksen DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem, 1972; 18: 499-502
26. Dorr M, Robinson DM, Wallaschofski H et al: Low serum thyrotropin is associated with high plasma fibrinogen. J Clin Endocrinol Metab, 2006; 91: 530-34
27. Lip GY, Lowe GD: Fibrin D-dimer: a useful clinical marker of thrombogenesis? Clin Sci, 1995; 89: 205-14
28. Sagripanti A, Carpi A, Baicchi U: The measurement of plasma D-dimer in the follow-up after thyroidectomy for cancer: preliminary data. Thyroidology, 1991; 3: 31-35
29. Chadarevian R, Bruckert E, Ankri A et al: Relationship between thyroid hormones and plasma D-dimer levels. Thromb Haemost, 1998; 79: 99-103
30. Chadarevian R, Bruckert E, Leenhardt L et al: Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism. J Clin Endocrinol Metab, 2001; 86: 732-37
31. Cantürk Z, Cetinarslan B, Tarkun I et al: Hemostatic system as a risk factor for cardiovascular disease in women with subclinical hypothyroidism. Thyroid, 2004; 14: 870
32. Biondi B, Palmieri EA, Lombardi G, Fazio S: Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med, 2002; 137: 904-14
33. Tenerz A, Forberg R, Jansson R: Is a more active attitude warranted in patients with subclinical thyrotoxicosis? J Intern Med, 1990; 228: 229-33
34. Sawin CT, Geller A, Wolf PA et al: Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med, 1994; 331: 1249-52
35. Auer J, Scheibner P, Mische T et al: Subclinical hyperthyroidism as a risk factor for atrial fibrillation. Am Heart J, 2001; 142: 838-42
36. Biondi B, Fazio S, Palmieri EA et al: Effects of chronic subclinical hyperthyroidism on cardiac morphology and function. Cardiologia, 1999; 44: 443-49
37. Sgarbi JA, Villaca F, Garbeline B et al: The effects of early antithyroid therapy for endogenous subclinical hyperthyroidism in clinical and heart abnormalities. J Clin Endocrinol Metab, 2003; 88: 1672-77
38. Biondi B, Palmieri EA, Filetti S et al: Mortality in elderly patients with subclinical hyperthyroidism. Lancet, 2002; 359: 799-800
39. Petretta M, Bonaduce D, Spinelli L et al: Cardiovascular haemodynamics and cardiac autonomic control in patients with subclinical and overt hyperthyroidism. Eur J Endocrinol, 2001; 145: 691-96
40. Parle JV, Maisonneuve P, Sheppard MC et al: Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet, 2001; 358: 861-65
41. Guldiken S, Demir M, Turgut B et al: Global fibrinolytic capacity in patients with subclinical hypothyroidism. Endocr J, 2005; 52: 363-67
42. Ogawa H, Suefuji H, Takazoe K et al: Difference in fibrinolytic activity between multivessel coronary spasm and one-vessel coronary spasm. Am J Cardiol, 2000; 85: 98-101
43. Wiman B, Andersson T, Hallqvist J et al: Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study. Arterioscler Thromb Vasc Biol, 2000; 20: 2019-23
44. Basaria S, Braga M: A rare form of hypothyroidism. South Med J, 2002; 95: 549-51
45. Galofre JC, Garcia-Mayor RV et al: Incidence of different forms of thyroid dysfunction and its degrees in an iodine sufficient area. Thyroidology, 1994; 6: 49-54